Channing Laboratory – The Channing Laboratory is one of Harvard’s foremost multidisciplinary research institutions. The Epidemiology section, led by Dr. Frank Speizer, is divided into five programs with significant overlap of both research and support staff. The Nurses’ Health Study is the longest-running and largest cohort study of risk factors for chronic diseases – such as cancer and diabetes – among women; it is one of three similar cohort studies currently conducted at the Channing Laboratory.
Austrian Scientists and Scholars in North America – ASciNA is an independent network and intellectual home of Austrian scientists from various disciplines. Dr. Schernhammer was co-founder of the network (2001) and between 2005 and 2008 served as president for the more than 1000 ASciNA members across North America.
Applied Biomarkers in Cancer Epidemiology EPI246 (site is under construction) – The focus of this course is on application and interpretation of cancer studies using biomarkers. Topics include biomarkers of exposure, biomarkers related to metabolism/activation and other biological pathways, intermediate/surrogate endpoints, markers of early cancer detection and prognosis.